Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026
RWA tokenization platform Libeara completes new funding round with participation from AlloyX Ventures
The crypto market declines broadly, with only the RWA sector seeing a slight increase.
Hyperliquid: RWA asset trading on the platform has repeatedly hit record highs in the past two weeks
Saeed Al Fahim and the Digital Evolution of Gulf Family Enterprises
Ethereum whales enter XAUT accumulation mode